BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 28295638)

  • 1. Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection.
    Yoshio T; Tomida H; Iwasaki R; Horiuchi Y; Omae M; Ishiyama A; Hirasawa T; Yamamoto Y; Tsuchida T; Fujisaki J; Yamada T; Mita E; Ninomiya T; Michitaka K; Igarashi M
    Dig Endosc; 2017 Sep; 29(6):686-694. PubMed ID: 28295638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study.
    Tomida H; Yoshio T; Igarashi K; Morita Y; Oda I; Inoue T; Hikichi T; Sumiyoshi T; Doyama H; Tsuji Y; Nishikawa J; Hatta W; Mikami T; Iguchi M; Sumiyama K; Yamamoto K; Kitamura K; Kuribayashi S; Yanagitani A; Uraoka T; Yada T; Hasatani K; Kawaguchi K; Fujita T; Nishida T; Hiasa Y; Fujishiro M;
    Gastric Cancer; 2021 Jan; 24(1):179-189. PubMed ID: 32683602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taking Warfarin with Heparin Replacement and Direct Oral Anticoagulant Is a Risk Factor for Bleeding after Endoscopic Submucosal Dissection for Early Gastric Cancer.
    Sanomura Y; Oka S; Tanaka S; Yorita N; Kuroki K; Kurihara M; Mizumoto T; Yoshifuku Y; Chayama K
    Digestion; 2018; 97(3):240-249. PubMed ID: 29421806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued Aspirin Treatment May Be a Risk Factor of Delayed Bleeding after Gastric Endoscopic Submucosal Dissection under Heparin Replacement: A Retrospective Multicenter Study.
    Hamada K; Kanzaki H; Inoue M; Ishiyama S; Yamauchi K; Miyahara K; Toyokawa T; Tsuzuki T; Miyaike J; Matsubara M; Takahashi S; Nishimura M; Takenaka R; Yunoki N; Hori S; Kobayashi S; Yamasaki Y; Kawahara Y; Ishikawa H; Okada H
    Intern Med; 2020 Nov; 59(21):2643-2651. PubMed ID: 32641658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants.
    Brodie MM; Newman JC; Smith T; Rockey DC
    Am J Med; 2018 May; 131(5):573.e9-573.e15. PubMed ID: 29175237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of anticoagulants on delayed bleeding after colorectal endoscopic submucosal dissection.
    Harada H; Nakahara R; Murakami D; Suehiro S; Nagasaka T; Ujihara T; Sagami R; Katsuyama Y; Hayasaka K; Tounou S; Amano Y
    Surg Endosc; 2020 Aug; 34(8):3330-3337. PubMed ID: 31482349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
    Adachi T; Hoshino H; Takagi M; Fujioka S;
    Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
    Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative bleeding in patients on antithrombotic therapy after gastric endoscopic submucosal dissection.
    Sato C; Hirasawa K; Koh R; Ikeda R; Fukuchi T; Kobayashi R; Kaneko H; Makazu M; Maeda S
    World J Gastroenterol; 2017 Aug; 23(30):5557-5566. PubMed ID: 28852315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risks and characteristics of the delayed bleeding after endoscopic submucosal dissection for early gastric carcinoma in cases with anticoagulants.
    Saito H; Igarashi K; Hirasawa D; Okuzono T; Suzuki K; Abe Y; Nawata Y; Tanaka Y; Tanaka I; Unno S; Nishikawa Y; Tsubokura M; Nakahori M; Chonan A; Matsuda T
    Scand J Gastroenterol; 2020 Oct; 55(10):1253-1260. PubMed ID: 32924673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Analysis of Delayed Bleeding in Cases of Colorectal Endoscopic Submucosal Dissection Due to Types of Direct Oral Anticoagulants in Japan.
    Yoshida N; Hayashi Y; Togo D; Oka S; Takada K; Fukunaga S; Morita Y; Hayashi T; Kozuka K; Tsuji Y; Murakami T; Yamamura T; Komeda Y; Takeuchi Y; Shinmura K; Fukuda H; Yoshii S; Ono S; Katsuki S; Kawashima K; Nemoto D; Yamamoto H; Saito Y; Tamai N; Iwao A; Itoi Y; Tsuji S; Inagaki Y; Inada Y; Soga K; Hasegawa D; Murakami T; Yoriki H; Fukumoto K; Motoyoshi T; Nakatani Y; Sano Y; Iguchi M; Fujii S; Ban H; Harada K; Okamoto K; Nishiyama H; Sasaki F; Mizukami K; Shono T; Shimoda R; Miike T; Yamaguchi N
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):271-282.e3. PubMed ID: 37743040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anticoagulants on the risk of delayed bleeding after colorectal endoscopic submucosal dissection.
    Ogiyama H; Inoue T; Maekawa A; Yoshii S; Yamaguchi S; Nagai K; Yamamoto M; Egawa S; Horimoto M; Ogawa H; Nishihara A; Komori M; Kizu T; Tsutsui S; Tsujii Y; Hayashi Y; Iijima H; Takehara T
    Endosc Int Open; 2020 Nov; 8(11):E1654-E1663. PubMed ID: 33140021
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: Insights from a nationwide cohort.
    Butt JH; Li A; Xian Y; Peterson ED; Garcia D; Torp-Pedersen C; Køber L; Fosbøl EL
    Am Heart J; 2019 Oct; 216():117-124. PubMed ID: 31425898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements.
    Pasciolla S; Zizza LF; Le T; Wright K
    Clin Drug Investig; 2020 Sep; 40(9):839-845. PubMed ID: 32607688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
    Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Novel Oral Antithrombotics With the Risk of Intraocular Bleeding.
    Uyhazi KE; Miano T; Pan W; VanderBeek BL
    JAMA Ophthalmol; 2018 Feb; 136(2):122-130. PubMed ID: 29242919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis.
    Lau LH; Guo CL; Yip TC; Mak JW; Wong SH; Lam KL; Wong GL; Ng SC; Chan FK
    Gut; 2022 Jan; 71(1):100-110. PubMed ID: 33619167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
    Steed MB; Swanson MT
    Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct oral anticoagulant drugs (DOAC).
    Blum RA; Lindfield D
    J Cataract Refract Surg; 2016 Jan; 42(1):171-2. PubMed ID: 26948793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.